000 01538 a2200457 4500
005 20250517154522.0
264 0 _c20180423
008 201804s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.17646
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSong, Chengcheng
245 0 0 _aA cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
_h[electronic resource]
260 _bOncotarget
_cJul 2017
300 _a47330-47343 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdjuvants, Immunologic
650 0 4 _aAnimals
650 0 4 _aAntibody Formation
_ximmunology
650 0 4 _aAntibody-Dependent Cell Cytotoxicity
650 0 4 _aAntigens, Tumor-Associated, Carbohydrate
_ximmunology
650 0 4 _aCancer Vaccines
_xadministration & dosage
650 0 4 _aCell Line, Tumor
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aDisease Models, Animal
650 0 4 _aFemale
650 0 4 _aFluorine
_xchemistry
650 0 4 _aImmunity
650 0 4 _aImmunity, Cellular
650 0 4 _aImmunization
650 0 4 _aImmunotherapy
650 0 4 _aMice
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aT-Lymphocyte Subsets
_ximmunology
700 1 _aZheng, Xiu-Jing
700 1 _aLiu, Chang-Cheng
700 1 _aZhou, Yifa
700 1 _aYe, Xin-Shan
773 0 _tOncotarget
_gvol. 8
_gno. 29
_gp. 47330-47343
856 4 0 _uhttps://doi.org/10.18632/oncotarget.17646
_zAvailable from publisher's website
999 _c27203993
_d27203993